Pancreatic Cancer Exceptional Responders and the Immune System Link
Dr. Vinod Balachandran looks at the immune system of exceptional responders–patients who respond extremely well to chemotherapy–for treatment clues.
New Research Sheds Light on Hot and Cold Tumors
Dr. Ben Z. Stanger and his team are finding links between the number of T cells a tumor has and the effectiveness of immunotherapy.
Stand Up To Cancer Announces $11M Collaborative, Multidisciplinary Research Program; Microsoft Will Bring Power of AI to Investigate Immune System Response to Cancers
Stand Up To Cancer launches a multidisciplinary collaborative research program with Microsoft Research using artificial intelligence.
Neoantigens Provide New Hope for Pancreatic Cancer Treatments
Vinod Balachandran’s team identified increased T cells in the tumors of long-term pancreatic cancer survivors, with a role for neoantigens in immunotherapy.
Targeted Therapy for Pancreatic Cancer
Dr. Margaret Tempero outlines the work being done in the area of targeted therapy for pancreatic cancer, specifically the testing of ibrutinib.
An Unexpected Diagnosis After Surgery
Lora Kelly had surgery to remove a cyst that turned out to be pancreatic cancer. Treatment including clinical trials keeps the cancer from returning.
Buying Time for Another Clinical Trial
Richard Valdes has alternated standard pancreatic cancer treatments with clinical trials of immunotherapy and a pancreatic vaccine during his treatment.
Living with Pancreatic Cancer
Camille Altgelt searched for clinical trials for her pancreatic cancer but did not qualify. Her treatment with chemotherapy and radiation was successful.
Putting the Immune System on the Offensive
A discussion of immunology in cancer treatment, focusing on the work of Elizabeth Jaffe, M.D., and her cancer vaccine and checkpoint inhibitors.
Comparing the Effectiveness of Vaccine Therapy With or Without Additional Immunotherapy
Exploring the effectiveness of the immunotherapy combination of cancer vaccines and a checkpoint blockade drug against metastatic pancreatic cancer.
